News · Peptide Therapeutic
189 stories
Sep 28, 26CDER director, expert discuss scientific, legal challenges to bringing generic GLP-1s to market
Sep 14, 26Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptide
Aug 28, 26Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data